[HTML][HTML] MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma
Abstract Background Therapeutic microRNAs (miRNAs) delivery holds a lot of promise for
treating human malignancies. So, this study was carried out to examine the potential of miR …
treating human malignancies. So, this study was carried out to examine the potential of miR …
[HTML][HTML] Nanoconjugated long non-coding RNA MEG3 as a new therapeutic approach for Hepatocellular carcinoma
Background Hepatocellular carcinoma (HCC) is an aggressive human cancer with a poor
prognosis. Long non-coding RNAs (lncRNA) have multiple functions: epigenomic regulation …
prognosis. Long non-coding RNAs (lncRNA) have multiple functions: epigenomic regulation …
NAC1 transcriptional activation of LDHA induces hepatitis B virus immune evasion leading to cirrhosis and hepatocellular carcinoma development
W Chen, L Guo, H Xu, Y Dai, J Yao, L Wang - Oncogenesis, 2024 - nature.com
Our study aimed to elucidate the molecular mechanisms underlying NAC1 (nucleus
accumbens associated 1) transcriptional regulation of LDHA and its role in HBV immune …
accumbens associated 1) transcriptional regulation of LDHA and its role in HBV immune …
Innovative model of surface-enhanced Raman spectroscopy for exosomes identification: An approach for the diagnosis of hepatocellular carcinoma
Background The current hepatocellular carcinoma (HCC) diagnostic approaches lack
adequate sensitivity and specificity. So, this study was performed to develop an innovative …
adequate sensitivity and specificity. So, this study was performed to develop an innovative …